Speaker illustration

Mr Or Levi

(Israel)

BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction

Event: ESC Congress 2024

Topic: Antiarrhythmic Drug Treatment

Session: Clinical and experimental arrhythmia treatments

Thumbnail